We are live on ! Find out more
CCM

Compass Capital Management Portfolio holdings

AUM $1.66B
1-Year Est. Return 7.83%
This Fund
S&P 500
This Quarter Est. Return
+4.89%
1 Year Est. Return
+7.83%
3 Year Est. Return
+47.1%
5 Year Est. Return
+55.91%
10 Year Est. Return
+237.22%
AUM
$444M
AUM Growth
+$33.4M
Cap. Flow
+$8.14M
Cap. Flow %
1.83%
Top 10 Hldgs %
33.84%
Holding
59
New
8
Increased
29
Reduced
15
Closed
4

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$860K
2
PFE icon
Pfizer
PFE
+$840K
3
SHW icon
Sherwin-Williams
SHW
+$785K
4
ACN icon
Accenture
ACN
+$701K
5
MSFT icon
Microsoft
MSFT
+$624K

Top Sells

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$675K
2
NVO
Novo Nordisk
NVO
+$343K
3
NOC icon
Northrop Grumman
NOC
+$292K
4
EXPD icon
Expeditors International
EXPD
+$250K
5
MRK icon
Merck
MRK
+$215K

Sector Composition

Rank Sector Weight
1 Healthcare 23.11%
2 Industrials 17.02%
3 Technology 15.59%
4 Consumer Staples 9.84%
5 Materials 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TGT icon
26
Target
TGT
$65B
$1.64M 0.37%
25,587
-55
-0.2% -$3.74K
BRK.A icon
27
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.36M 0.31%
8
-1
-11% -$173K
XOM icon
28
ExxonMobil
XOM
$639B
$1.24M 0.28%
14,413
-815
-5% -$73.5K
OMC icon
29
Omnicom Group
OMC
$21.9B
$1.01M 0.23%
15,852
– –
WFC icon
30
Wells Fargo
WFC
$259B
$882K 0.2%
21,338
-1,635
-7% -$69.8K
PFE icon
31
Pfizer
PFE
$141B
$841K 0.19%
+30,856
New +$840K
IBM icon
32
IBM
IBM
$208B
$835K 0.19%
4,719
+987
+26% +$179K
CVX icon
33
Chevron
CVX
$385B
$710K 0.16%
5,841
+381
+7% +$46.8K
MMM icon
34
3M
MMM
$90.4B
$581K 0.13%
+5,822
New +$566K
PEP icon
35
PepsiCo
PEP
$190B
$446K 0.1%
5,614
+1,100
+24% +$90.4K
MCD icon
36
McDonald's
MCD
$190B
$415K 0.09%
4,316
+1,962
+83% +$192K
DIS icon
37
Walt Disney
DIS
$167B
$278K 0.06%
+4,315
New +$277K
HD icon
38
Home Depot
HD
$330B
$273K 0.06%
3,604
– –
EMR icon
39
Emerson Electric
EMR
$83.6B
$246K 0.06%
+3,806
New +$233K
CL icon
40
Colgate-Palmolive
CL
$72.4B
$238K 0.05%
4,020
-300
-7% -$17.8K
SLB icon
41
SLB Ltd
SLB
$73.3B
$221K 0.05%
+2,500
New +$205K
RTX icon
42
RTX Corp
RTX
$287B
$212K 0.05%
+3,122
New +$204K
KMB icon
43
Kimberly-Clark
KMB
$36.2B
$206K 0.05%
+2,283
New +$212K
MRK icon
44
Merck
MRK
$319B
– –
-4,859
Closed -$215K
NOC icon
45
Northrop Grumman
NOC
$75.7B
– –
-3,522
Closed -$292K
NVO
46
Novo Nordisk
NVO
$207B
– –
-22,130
Closed -$343K
1
2

Similar funds

BFPW
BOK Financial Private Wealth Denver, Colorado $1.66B AUM 18.56% 1-Year Est. Return
PP
Patten & Patten Chattanooga, Tennessee $1.66B AUM 18.12% 1-Year Est. Return
ACM
Anomaly Capital Management New York $1.65B AUM 26.47% 1-Year Est. Return
RIA
Recurrent Investment Advisors Houston, Texas $1.66B AUM 38.27% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
TIAA Trust, National Association
TIAA Trust, National Association Charlotte, North Carolina $1.65B AUM 16.63% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return

Compass Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Compass Capital Management held 59 positions worth $444M, up 8.1% from $411M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Compass Capital Management's Q3 2013 filing shows 8 new, 29 increased, 15 reduced and 4 closed positions. Its largest new stake was Pfizer: 30,856 shares worth $841K. The largest sale was Johnson Controls International, an estimated $675K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Technology.

  • Compass Capital Management's largest Q3 2013 buy was Pfizer: 30,856 shares worth $841K.
  • Compass Capital Management added most to Walmart Inc in Q3 2013, an estimated $860K increase.
  • Compass Capital Management's biggest Q3 2013 reduction was Johnson Controls International, cutting an estimated $675K.
  • Compass Capital Management fully exited Novo Nordisk in Q3 2013, selling an estimated $343K.
  • Compass Capital Management's ten largest holdings make up 34% of its $444M portfolio in Q3 2013.
  • Compass Capital Management opened 8 new positions and closed 4 in Q3 2013.
  • Compass Capital Management's portfolio value rose 8.1% quarter-over-quarter to $444M.

Based on Compass Capital Management's 13F filing for Q3 2013, filed 24 Oct 2013.